BLUEFIN CAPITAL MANAGEMENT, LLC
Position in RNA — Atrium Therapeutics, Inc.
CIK 1144208
NEW YORK, NY
Position in RNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$215,347
New position
Shares Held
16,011
first reported quarter
Ownership
0.094%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#81
of 154 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BLUEFIN CAPITAL MANAGEMENT, LLC holds $215,347 across 1 Biotechnology name. RNA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
This page
|
16,011 | $215,347 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,347 | 16,011 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||